ATP5F1A
ATP synthase F(1) complex subunit alpha, mitochondrial
Also known as: ATP5A, ATP5A1, ATP5AL2, ATPA_HUMAN, ATPM, hATP1, OMR, ORM
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P25705
- Gene
- ATP5F1A
- Ensembl
- ENSG00000152234
- Chromosome
- 18
- Canonical length
- 553 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters
- Subcellular location
- Mitochondria,End piece
- Quaternary structure
- Homooctamer
OverviewNCBI Gene
This gene encodes a subunit of mitochondrial ATP synthase. Mitochondrial ATP synthase catalyzes ATP synthesis, using an electrochemical gradient of protons across the inner membrane during oxidative phosphorylation. ATP synthase is composed of two linked multi-subunit complexes: the soluble catalytic core, F1, and the membrane-spanning component, Fo, comprising the proton channel. The catalytic portion of mitochondrial ATP synthase consists of 5 different subunits (alpha, beta, gamma, delta, and epsilon) assembled with a stoichiometry of 3 alpha, 3 beta, and a single representative of the other 3. The proton channel consists of three main subunits (a, b, c). This gene encodes the alpha subunit of the catalytic core. Alternatively spliced transcript variants encoding the different isoforms have been identified. Pseudogenes of this gene are located on chromosomes 9, 2, and 16. [provided by RefSeq, Mar 2012]
Canonical amino-acid sequenceUniProt
553 residues, UniProt reviewed canonical sequence.
>P25705|ATP5F1A
1 MLSVRVAAAV VRALPRRAGL VSRNALGSSF IAARNFHASN THLQKTGTAE MSSILEERIL
61 GADTSVDLEE TGRVLSIGDG IARVHGLRNV QAEEMVEFSS GLKGMSLNLE PDNVGVVVFG
121 NDKLIKEGDI VKRTGAIVDV PVGEELLGRV VDALGNAIDG KGPIGSKTRR RVGLKAPGII
181 PRISVREPMQ TGIKAVDSLV PIGRGQRELI IGDRQTGKTS IAIDTIINQK RFNDGSDEKK
241 KLYCIYVAIG QKRSTVAQLV KRLTDADAMK YTIVVSATAS DAAPLQYLAP YSGCSMGEYF
301 RDNGKHALII YDDLSKQAVA YRQMSLLLRR PPGREAYPGD VFYLHSRLLE RAAKMNDAFG
361 GGSLTALPVI ETQAGDVSAY IPTNVISITD GQIFLETELF YKGIRPAINV GLSVSRVGSA
421 AQTRAMKQVA GTMKLELAQY REVAAFAQFG SDLDAATQQL LSRGVRLTEL LKQGQYSPMA
481 IEEQVAVIYA GVRGYLDKLE PSKITKFENA FLSHVVSQHQ ALLGTIRADG KISEQSDAKL
541 KEIVTNFLAG FEALocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATP5F1A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 1,644 nTPM
Expression across tissuesHPA
Tissue
- tongue: 1,644 nTPM
- skeletal muscle: 1,501 nTPM
- heart muscle: 1,409 nTPM
- parathyroid gland: 815 nTPM
- choroid plexus: 760 nTPM
- kidney: 682 nTPM
Single-cell type
- parietal cells: 912 nCPM
- cytotrophoblasts: 910 nCPM
- esophageal suprabasal cells: 840 nCPM
- migrating cytotrophoblasts: 804 nCPM
- esophageal basal cells: 785 nCPM
- syncytiotrophoblasts: 594 nCPM
Immune cell
- total PBMC: 1,340 nTPM
- myeloid DC: 961 nTPM
- classical monocyte: 575 nTPM
- T-reg: 529 nTPM
- intermediate monocyte: 513 nTPM
- naive CD4 T-cell: 505 nTPM
Brain region
- choroid plexus: 620 nTPM
- cerebral cortex: 291 nTPM
- hypothalamus: 288 nTPM
- midbrain: 276 nTPM
- medulla oblongata: 265 nTPM
- cerebellum: 260 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ATP5F1A.
Disease | AllUniProt
Conditions ATP5F1A is implicated in, by any mechanism.
- Combined oxidative phosphorylation deficiency 22 (COXPD22) MIM:616045
- Mitochondrial complex V deficiency, nuclear type 4A (MC5DN4A) MIM:620358
- Mitochondrial complex V deficiency, nuclear type 4B (MC5DN4B) MIM:615228
Disease | GeneticClinVar
5 pathogenic / likely-pathogenic of 314 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Combined oxidative phosphorylation deficiency 22
- Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4A
- Lactic acidosis
- ATP5F1A-related disorder
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.18
- gnomAD pLI
- 1
- DepMap mean gene effect
- -0.67
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- ATP biosynthetic process
- cellular response to dexamethasone stimulus
- cellular response to nitric oxide
- lipid metabolic process
- negative regulation of endothelial cell proliferation
- positive regulation of blood vessel endothelial cell migration
- proton motive force-driven ATP synthesis
- proton motive force-driven mitochondrial ATP synthesis
- response to ethanol
- response to muscle activity
Molecular functions
- ADP binding
- angiostatin binding
- ATP binding
- ATP hydrolysis activity
- MHC class I protein binding
- protease binding
- proton-transporting ATP synthase activity, rotational mechanism
- RNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- ATPase, F1/V1/A1 complex, alpha/beta subunit, nucleotide-binding domain
- ATPase, F1/V1/A1 complex, alpha/beta subunit, N-terminal domain
- ATPase, alpha/beta subunit, nucleotide-binding domain, active site
- ATP synthase subunit alpha, N-terminal domain-like superfamily
- P-loop containing nucleoside triphosphate hydrolase
- ATPase, F1/V1/A1 complex, alpha/beta subunit, N-terminal domain superfamily
- ATP synthase alpha/beta family, nucleotide-binding domain
- ATP synthase alpha/beta family, beta-barrel domain
- ATP synthase, alpha subunit, C-terminal
- ATP synthase, F1 complex, alpha subunit
- ATP synthase, F1 complex, alpha subunit nucleotide-binding domain
- ATP synthase, alpha subunit, C-terminal domain superfamily
- ATP synthase alpha/beta chain, C terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ATP5F1A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATP5F1A as an antibody target. Whether an autoantibody or antibody against ATP5F1A could matter depends on whether native ATP5F1A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATP5F1A is annotated at the cell surface, where native ATP5F1A is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ATP5F1A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...